Clinical Trial Update: Prolonged Release Pirfenidone Versus Placebo in Compensated Cirrhosis. [Phase 2]

View source ↗

Summary

Phase 2 trial comparing prolonged-release pirfenidone to placebo in compensated cirrhosis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis Liver
• Liver Disease
• Liver Fibrosis

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: Jorge L Poo | Conditions: Liver Fibrosis, Cirrhosis, Liver | Phase 2 | Status: COMPLETED